Clinical Trial Update: Cisplatin and Etoposide Plus Radiation Followed By Nivolumab/Placebo For Locally Advanced NSCLC [Phase 3]

View source ↗

Summary

A phase 3 trial evaluating cisplatin and etoposide with radiation followed by nivolumab vs placebo in locally advanced non-small cell lung cancer has been termi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Etoposide (Etoposide)
• nivolumab (nivolumab)

Snippet

Sponsor: RTOG Foundation, Inc. | Conditions: Non-Small Cell Lung Cancer | Phase 3 | Status: TERMINATED | Results posted: 2020-02-25